Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New Season is a leading provider of specialized healthcare services focused on treating opioid use disorder (OUD) through a network of over 80 accredited clinics across the United States. The company utilizes a Medication-Assisted Treatment (MAT) model, integrating FDA-approved medications such as methadone and buprenorphine with comprehensive counseling and medical support. Their programs are designed to address the physiological and psychological aspects of addiction, facilitating long-term recovery for patients. In 2024, New Season was acquired by Orlando Health, a major non-profit healthcare organization, to enhance its behavioral health and addiction medicine capabilities. The organization operates in approximately 20 states, providing essential access to recovery resources in communities heavily impacted by the opioid crisis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New Season.